SKOKIE, IL (August 19, 2025)—Caity Tirakian has been named a Senior Associate with Skokie, IL-based Stage Equity Partners, LLC. The announcement was made by Brian Howard, Stage Equity’s President and Founder.
“Caity has an impressive professional and academic background. She is a very talented, hard working and thoughtful individual, with an ability to underwrite acquisitions and identify new opportunities for growth,” Howard said. “We are excited for Caity’s contributions as we further expand our national healthcare real estate portfolio.”
In her role as a senior associate, Tirakian is responsible for guiding acquisition activities at Stage Equity, from initial underwriting through closing. At Stage she will leverage more than five years of experience in the commercial real estate industry, specifically in the areas of financial analysis and underwriting, macro and microeconomic research, due diligence coordination, and transaction oversight.
Immediately prior to joining Stage, Tirakian was a Senior Analyst on the Midwest Retail Investment Sales team at Jones Lang LaSalle. She began her career in commercial real estate with ShopCore Properties, a Blackstone retail portfolio group.
Tirakian earned a Bachelor of Business Administration in Real Estate & Urban Land Economics and Finance from the University of Wisconsin–Madison. She is a board member of the Wisconsin Real Estate Alumni Association (WREAA) and serves her community on the Chicago Associate Board for the National Alliance on Mental Illness (NAMI).
About Stage Equity Partners, LLC
Stage Equity Partners LLC is a Chicago-based private real estate investment firm focused on healthcare assets. The firm acquires, develops and manages high quality medical office buildings and healthcare facilities across the country. Stage has acquired more than 45 buildings in nine states, for its own account and for investor partners. Stage’s focus is on select medical acquisitions in strong, established demographic areas in close proximity to dominant hospital systems or other significant demand drivers. Targeted acquisitions typically range from $5MM to $25MM range, where Stage seeks to create yield premiums and additional opportunities for its investors and itself.
# # #
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
